🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

56+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 16 of 56 recruiting trials for “chordoid-glioma”

EARLY_Phase 1RecruitingNCT04943913 ↗

Study of GC101 TIL in Brain Glioma (Soochow2)

👨‍⚕️ Qing Lan, Second Affiliated Hospital of Soochow University📍 1 site📅 Started May 2021View details ↗
NARecruitingNCT04699773 ↗

LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)

🏥 University of Maryland, Baltimore📍 5 sites📅 Started Feb 2021View details ↗
RecruitingNCT04832620 ↗

Image Assisted Optimization of Proton Radiation Therapy in Chordomas and Chondrosarcomas

👨‍⚕️ Stijn Krol, MD PhD, LUMC/HollandPTC📍 2 sites📅 Started Feb 2021View details ↗
RecruitingNCT04975139 ↗

Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State Networks

👨‍⚕️ Jiayi Huang, M.D., Washington University School of Medicine📍 1 site📅 Started Sep 2020View details ↗
NARecruitingNCT04373720 ↗

MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas

👨‍⚕️ Melissa Chen, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Mar 2020View details ↗
Phase 2RecruitingNCT03991832 ↗

Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors

👨‍⚕️ Eric Chen, M.D., Princess Margaret Cancer Centre📍 1 site📅 Started Dec 2019View details ↗
Phase 2RecruitingNCT03886311 ↗

Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma

👨‍⚕️ Sant P Chawla, MD, Sarcoma Oncology Center📍 1 site📅 Started May 2019View details ↗
NARecruitingNCT03910465 ↗

Children and Adults With Chordoma

👨‍⚕️ Mary F Wedekind Malone, D.O., National Cancer Institute (NCI)📍 1 site📅 Started Apr 2019View details ↗
NARecruitingNCT03761121 ↗

Developing Fast Pediatric Imaging

👨‍⚕️ Kawin Setsompop, PhD, Boston Children Hospital/ Massachusetts General Hospital📍 3 sites📅 Started Apr 2019View details ↗
NARecruitingNCT03684109 ↗

Non-invasive Glioma Characterization Through Molecular Imaging

👨‍⚕️ Macarena De La Fuente, MD, University of Miami📍 1 site📅 Started Jan 2019View details ↗
Phase 4RecruitingNCT03048084 ↗

Seizure Treatment in Glioma

🏥 Leiden University Medical Center📍 5 sites📅 Started Feb 2018View details ↗
NARecruitingNCT02838602 ↗

Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant Tumors

👨‍⚕️ Pascal POMMIER, MD, Centre Leon Berard📍 21 sites📅 Started Dec 2017View details ↗
NARecruitingNCT02986516 ↗

Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease

👨‍⚕️ Alessandro Gronchi, MD, Istituto Nazionale Tumori Milan-Italy📍 28 sites📅 Started Mar 2017View details ↗
Phase 1, PHASE2RecruitingNCT01906385 ↗

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

👨‍⚕️ Andrew J Brenner, PhD, The Cancer Therapy and Research Center at UTHSCSA📍 3 sites📅 Started Jun 2015View details ↗
RecruitingNCT01772771 ↗

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

👨‍⚕️ Funda Meric-Bernstam, M.D. Anderson Cancer Center📍 1 site📅 Started Mar 2012View details ↗
NARecruitingNCT00870129 ↗

Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors

👨‍⚕️ Robert Young, MD, Memorial Sloan Kettering Cancer Center📍 1 site📅 Started Mar 2009View details ↗
← PreviousPage 3 of 3

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →